Viewing Study NCT06353360


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2025-12-27 @ 10:54 PM
Study NCT ID: NCT06353360
Status: RECRUITING
Last Update Posted: 2024-08-09
First Post: 2024-03-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.
Sponsor: Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module